MFDS
- Marketing authorisation holder: GENENTECH INC
- Status: likely_approved
🇰🇷 Xofluza in South Korea
Xofluza (BALOXAVIR) regulatory status in South Korea.
Marketing authorisation
Xofluza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Xofluza approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Xofluza in South Korea?
GENENTECH INC holds the South Korean marketing authorisation.